These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 11454718)
1. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. Nicholson SA; Okby NT; Khan MA; Welsh JA; McMenamin MG; Travis WD; Jett JR; Tazelaar HD; Trastek V; Pairolero PC; Corn PG; Herman JG; Liotta LA; Caporaso NE; Harris CC Cancer Res; 2001 Jul; 61(14):5636-43. PubMed ID: 11454718 [TBL] [Abstract][Full Text] [Related]
2. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Irwin M; Marin MC; Phillips AC; Seelan RS; Smith DI; Liu W; Flores ER; Tsai KY; Jacks T; Vousden KH; Kaelin WG Nature; 2000 Oct; 407(6804):645-8. PubMed ID: 11034215 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071 [TBL] [Abstract][Full Text] [Related]
4. Role of the p53-homologue p73 in E2F1-induced apoptosis. Stiewe T; Pützer BM Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847 [TBL] [Abstract][Full Text] [Related]
5. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Lissy NA; Davis PK; Irwin M; Kaelin WG; Dowdy SF Nature; 2000 Oct; 407(6804):642-5. PubMed ID: 11034214 [TBL] [Abstract][Full Text] [Related]
6. E1A activates transcription of p73 and Noxa to induce apoptosis. Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378 [TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734 [TBL] [Abstract][Full Text] [Related]
8. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146 [TBL] [Abstract][Full Text] [Related]
9. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. Gorgoulis VG; Zacharatos P; Mariatos G; Kotsinas A; Bouda M; Kletsas D; Asimacopoulos PJ; Agnantis N; Kittas C; Papavassiliou AG J Pathol; 2002 Oct; 198(2):142-56. PubMed ID: 12237873 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene. Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436 [TBL] [Abstract][Full Text] [Related]
11. The human p73 promoter: characterization and identification of functional E2F binding sites. Seelan RS; Irwin M; van der Stoop P; Qian C; Kaelin WG; Liu W Neoplasia; 2002; 4(3):195-203. PubMed ID: 11988839 [TBL] [Abstract][Full Text] [Related]
12. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma. Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938 [TBL] [Abstract][Full Text] [Related]
13. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942 [TBL] [Abstract][Full Text] [Related]
14. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription. Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705 [TBL] [Abstract][Full Text] [Related]
15. Oncogenes induce and activate endogenous p73 protein. Zaika A; Irwin M; Sansome C; Moll UM J Biol Chem; 2001 Apr; 276(14):11310-6. PubMed ID: 11115495 [TBL] [Abstract][Full Text] [Related]
16. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210 [TBL] [Abstract][Full Text] [Related]
18. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells. Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992 [TBL] [Abstract][Full Text] [Related]
19. From p63 to p53 across p73. Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031 [TBL] [Abstract][Full Text] [Related]